Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Other material
confidence 72%
filed 2026-05-20
Item 1.02
The filing discloses termination of a Cooperation Agreement between Entravision and the Stockholders (widow of former CEO Walter Ulloa and related trusts) that had governed board nomination rights and stockholder commitments since May 2023. While the termination itself is administrative, the agreement involved material governance arrangements and a significant shareholder relationship tied to the company's former leadership. The event does not fit neatly into the specific taxonomy categories (not an M&A activity, not a covenant breach, not a going-concern issue), making "other_material" the most appropriate classification for this governance-related termination.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-05-20
Item 7.01
The filing discloses a quarterly shareholder update for Q1 2026 under Item 7.01 (Regulation FD Disclosure), furnished but not filed. While this is a routine quarterly communication to shareholders, it does not fit the earnings_release category (which typically involves formal financial results as a press release exhibit) nor any other specific event type. The update would be material to shareholders assessing fund performance and status, warranting classification as other_material rather than a more specific category.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-05-20
Item 1.01
The filing discloses entry into a material definitive Underwriting Agreement for the issuance of $1.375 billion in Series 2026-A Senior Secured SAC Bonds by Appalachian Power Recovery Funding LLC, with Goldman Sachs, J.P. Morgan, and RBC Capital Markets as underwriters. While this is a debt issuance rather than a traditional M&A transaction, it represents a material financing activity that restructures the capital stack and involves multiple definitive agreements (Underwriting Agreement, Indenture, Intercreditor Agreement, Servicing Agreement, Purchase and Sale Agreement, and Administration Agreement). The magnitude ($1.375B) and complexity of the transaction structure make it material to investors' assessment of the registrant's financial position and capital strategy.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-20
Item 8.01
Akamai announced the pricing of $3 billion in aggregate principal amount of convertible senior notes ($1.5 billion due 2030 and $1.5 billion due 2032) in a private offering to qualified institutional buyers. This is a material dilutive issuance of convertible debt securities that will likely result in equity dilution upon conversion, consistent with Item 3.02 disclosure requirements and the dilutive_issuance event type.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-20
Item 8.01
The filing discloses an amendment to an Equity Purchase Agreement for the sale of the Company's Flyover flying theater attractions business to Flyover Attractions B.V., extending the outside termination date from May 21, 2026 to July 31, 2026. This constitutes material M&A activity—specifically a disposition of a business unit—that would materially affect a reasonable investor's assessment of the registrant's operations and financial position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 5.02
Robert D. Wright was appointed as President and Chief Executive Officer of Wendy's, effective May 21, 2026, and elected to the Board of Directors. The appointment includes compensatory arrangements with a base salary of $1 million, a performance-based bonus target of 175%, and LTIP awards totaling $5.5 million.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 8.01
Lumen announced early results of cash tender offers for approximately $750 million in outstanding debt across multiple subsidiaries and note series. While debt repurchase activity can signal financial management or refinancing strategy, this disclosure does not fit cleanly into the more specific event categories (not M&A, not a covenant breach, not a restatement or going-concern issue). The tender offer itself—a material debt reduction initiative—is a significant corporate action affecting the capital structure and financial obligations of the registrant, warranting classification as a material event outside the standard taxonomy.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-20
Item 1.01
The filing discloses entry into a second amended and restated LLC agreement for AGL EPCI I involving the admission of new members (AIMCo and additional Vintage Strategies vehicles) and a $54 million transfer of LLC interests. This constitutes a material change in the ownership and capital structure of an unconsolidated entity in which the Company holds interests, meeting the threshold for Item 1.01 material definitive agreement disclosure and representing a material transaction affecting the Company's investment portfolio.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 8.01
American Water's finance subsidiary closed a $500 million senior notes offering on May 20, 2026, with net proceeds of approximately $498 million. While this is a material financing event that would affect investor assessment of the company's capital structure and liquidity, it does not fit cleanly into the dilutive_issuance category (which typically applies to equity securities or convertibles) nor any other more specific event type. The disclosure centers on debt issuance and refinancing activity rather than a discrete material event like M&A, impairment, or covenant breach.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder voting results from Uwharrie Capital Corp's Annual Meeting of Shareholders held on May 19, 2026. The filing presents detailed vote tallies for four proposals: election of seven board directors, ratification of executive compensation resolution, frequency of advisory votes on compensation, and appointment of independent auditor. This is a textbook Item 5.07 disclosure and is material as it reflects shareholder approval of key governance matters including board composition and auditor appointment.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-05-20
Item 5.02
Eric Mellen, the Chief Financial Officer and Treasurer, provided notice of retirement effective June 10, 2026. The principal disclosed action is a named executive officer departing from his role. While the company notes it has begun a search for a replacement, the core event is the departure itself, making exec_departure the appropriate classification.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-05-20
Item 5.02
The disclosure centers on shareholder approval of the First Amendment to the 2020 Equity Incentive Plan, which increases the share pool by 3,000,000 shares and extends the plan term to 2036. This is a material compensatory arrangement amendment affecting equity grants available to officers and directors, disclosed under Item 5.02(e) and approved at the May 14, 2026 Annual Meeting of Shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-05-20
Item 3.02
AB Private Lending Fund completed an unregistered sale of 4,045 Class I common shares of beneficial interest to feeder vehicles under Section 4(a)(2) and Regulation S exemptions. This private placement raises capital while diluting existing shareholders' ownership interests.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 8.01
The filing discloses the Company's Net Asset Value (NAV) per share as of April 30, 2026, across six classes of common shares and OP Units, calculated in accordance with board-approved valuation guidelines. While NAV reporting is a routine disclosure for REITs and non-traded funds, the detailed breakdown of NAV components and per-share values across multiple share classes would be material to investors evaluating the fund's performance and share pricing. This does not fit neatly into the more specific event categories (not earnings, not an executive change, not M&A, etc.), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 8.01
This disclosure reports the Company's Net Asset Value (NAV) per share as of April 30, 2026, broken down by share class, along with a detailed calculation of total NAV and its components. For a non-traded REIT like Fortress Credit Realty Income Trust, NAV per share is a critical valuation metric that directly informs investor pricing and redemption decisions. While this is a routine periodic disclosure for REITs, it is material to investors assessing the registrant's asset value and performance. The filing does not fit neatly into more specific event categories (not earnings, not M&A, not impairment, etc.), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on May 20, 2026, covering three proposals: election of seven directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The filing directly matches Item 5.07 requirements and presents detailed vote tallies for each matter, making it material to investors' understanding of corporate governance and stakeholder approval.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
Inovio Pharmaceuticals held its 2026 Annual Meeting of Stockholders on May 20, 2026, with shareholders voting on four proposals: election of eight directors, ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and approval of an amended 2023 Omnibus Incentive Plan. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-20
Item 3.02
The filing discloses an unregistered sale of 211,900 Shares in a private placement to accredited investors under Rule 506(c) of Regulation D, representing an aggregate of 4,038.87 TAO worth $1,149,569. This is a classic dilutive issuance exempt from registration requirements, with Grayscale Securities acting as Authorized Participant and potential underwriter. The disclosure explicitly references Item 3.02 (Unregistered Sales of Equity Securities) and notes that periodic share creation may constitute ongoing distributions.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 8.01
The Centers for Medicare & Medicaid Services expanded Medicare coverage for Personalis's NeXT Personal® test to include a new clinical indication (monitoring treatment response to neoadjuvant therapy in Stage II-III breast cancer patients). This regulatory approval expands the addressable market and revenue potential for a key product, which is material to investors. However, the event does not fit neatly into more specific categories (not an earnings release, M&A activity, impairment, or litigation), so it is classified as other_material.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-20
Item 1.01
The filing discloses entry into a material definitive agreement for the sale of The Pike Outlets (Long Beach, California) for approximately $50.0 million in gross proceeds ($46.0 million net). This is a disposition of a material asset by SITE Centers Corp. through its subsidiary, meeting the definition of ma_activity under Item 1.01. The transaction is material to investors as it represents a significant asset sale with expected closing by Q3 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-05-20
Item 5.02
Scott Hortenstine is being designated as Sabre's principal accounting officer and Vice President and Controller, effective July 1, 2026. This is a material executive appointment to a key financial reporting role. While the disclosure also notes that Jami Kindle will continue as principal accounting officer through June 30, 2026, the principal disclosed action is Hortenstine's appointment to this critical position, making this an exec_appointment event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-05-20
Item 8.01
This Item 8.01 disclosure reports the completion of a material asset sale: Lumen sold its Mass Markets fiber-to-the-home business across 11 states for $5.75 billion in gross cash proceeds (approximately $5.72 billion net). The company used proceeds to redeem substantial debt and repay credit facilities, representing a significant capital restructuring. Although the sale was initially reported in a February 2, 2026 Form 8-K, this filing provides updated pro forma financial information in connection with an S-4 registration statement, confirming the materiality and ongoing relevance of the transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This Item 5.07 disclosure reports the results of Verra Mobility's 2026 annual meeting of stockholders held on May 19, 2026, including voting outcomes on four proposals: election of three Class II directors, approval of executive compensation on a non-binding basis, approval of annual say-on-pay frequency, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents vote tallies (votes for, against, withheld, abstentions, and broker non-votes) for each proposal, which is the standard format for shareholder vote result disclosures under Item 5.07.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-05-20
Item 5.02
Patrick S. Pacious stepped down as President & CEO effective May 20, 2026, which is the principal disclosed action. While the filing also discloses the appointment of Dominic E. Dragisich as Interim CEO and compensatory arrangements for both executives, the salient event is the departure of the sitting CEO. The filing centers on the "leadership transition" triggered by Pacious's departure and includes detailed severance terms reflecting his executive status.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
Alkermes plc held its Annual Meeting on May 20, 2026, with shareholders voting on six matters: election of nine directors, advisory vote on named executive officer compensation, ratification of PricewaterhouseCoopers LLP as auditor, approval of amendments to the 2018 Stock Option and Incentive Plan (increasing authorized shares by 5,900,000), renewal of Board authority to allot and issue shares, and renewal of Board authority to disapply pre-emption rights. All matters received shareholder approval with detailed vote tallies disclosed.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 1.01
Sotera Health entered into Amendment No. 7 to its First Lien Credit Agreement on May 20, 2026, refinancing approximately $1.42 billion in term loans with a 0.25% reduction in interest rate spread and extending maturity to May 30, 2031.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-05-20
Item 1.01
Rehan Jaffer will be appointed to Six Flags' board of directors as a Class III director following the May 26, 2026 Annual Meeting, replacing departing director Arik Ruchim. The appointment is part of a Cooperation Agreement with H Partners, a significant long-term investor, and includes assignment to the Audit and Finance Committee, voting agreements, and standstill provisions affecting shareholder governance.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This Item 5.07 filing discloses the results of the 2026 Annual Meeting of Shareholders held on May 19, 2026, including voting outcomes on three matters: election of nine directors (all elected with substantial majorities), advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The disclosure of shareholder vote results is a core Item 5.07 event and is material to investors as it confirms board composition and auditor ratification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This Item 5.07 disclosure presents the complete results of Con Edison's Annual Meeting of Stockholders held on May 18, 2026, including detailed voting tallies for the election of 11 directors, ratification of PricewaterhouseCoopers LLP as independent accountants, and an advisory vote on named executive officer compensation. The filing directly matches the shareholder_vote_results taxonomy definition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from DNOW Inc.'s Annual Meeting of Stockholders held on May 20, 2026. The filing presents detailed voting tallies for three matters: election of nine directors, ratification of KPMG LLP as independent auditors, and advisory approval of named executive officer compensation. All three matters were approved by stockholders with substantial majorities, making this a standard shareholder vote results disclosure that is material to investors as it confirms governance and audit arrangements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes on four proposals: election of two Class III directors (Jean Franchi and Hany Massarany), advisory approval of named executive officer compensation, frequency of advisory votes on compensation, and ratification of KPMG LLP as independent auditor. All proposals passed with substantial majorities. This is material as it documents formal stockholder actions and governance outcomes.
View raw filing on EDGAR →
8-K
Exec departure
confidence 72%
filed 2026-05-20
Item 5.02
William E. Berry, Jr., Vice President and Chief Accounting Officer, is retiring effective September 1, 2026. While the filing also discloses Emily Baculik's appointment as his successor and compensatory arrangements for both executives, the principal disclosed action centers on Berry's departure from his officer role. The retirement of a named executive officer responsible for accounting oversight is material to investors assessing management continuity and financial reporting controls.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 8.01
Wesbanco's Board approved a new stock repurchase program authorizing up to 4.0 million shares, which is a material capital allocation decision affecting shareholder value and future earnings per share. While this is a routine corporate governance action, the authorization of a substantial share buyback program would affect a reasonable investor's assessment of the company's capital strategy and financial position, making it material despite not fitting neatly into more specific event categories.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-05-20
Item 5.07
This Item 5.07 filing discloses the results of Fold Holdings' Annual Meeting of Stockholders held on May 19, 2026, including voting outcomes for two proposals: election of two Class I directors (Bracebridge H. Young, Jr. and Andrew Hohns) and ratification of CBIZ CPAs P.C. as independent auditor. The tabulated vote counts for each proposal are the core disclosure, matching the shareholder_vote_results taxonomy precisely.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder vote results from Lake Shore Bancorp's Annual Meeting of Shareholders held on May 20, 2026. The filing presents detailed vote tabulations for all four proposals: election of three Class Three directors, advisory vote on named executive officer compensation, frequency of advisory compensation votes, and ratification of the independent auditor. The vote counts and outcomes are explicitly stated, matching the definition of Item 5.07 shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a classic Item 5.07 disclosure of shareholder vote results from Motorola Solutions' 2026 Annual Meeting of Shareholders held on May 18, 2026. The filing reports voting outcomes for three proposals: election of eight directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of executive compensation. All three proposals passed with substantial majorities, making this a material disclosure of shareholder meeting outcomes.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-05-20
Item 5.02
Mark Weinswig resigned as Chief Financial Officer, effective June 15, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 7.01
Andrew Clipsham was appointed as Interim Chief Financial Officer, effective upon Weinswig's departure.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 8.01
Eli Lilly completed a substantial $8.94 billion debt offering across eight series of notes with varying maturities and interest rates, including a contingent mandatory redemption provision tied to the Centessa Acquisition. While this is a material financing event affecting the company's capital structure and liquidity, it does not fit neatly into the standard 8-K taxonomy (not an earnings release, M&A completion, impairment, or other specifically enumerated event type). The disclosure is material to investors as it reflects significant new debt obligations and conditional redemption terms dependent on an acquisition outcome.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This Item 5.07 disclosure reports the results of Bausch & Lomb's Annual Meeting of Shareholders held on May 20, 2026, including voting outcomes on three proposals: election of ten directors, advisory vote on executive compensation, and appointment of PricewaterhouseCoopers LLP as independent auditor. The filing presents vote tallies (For, Against, Abstain, Broker Non-Votes) for each matter, which is the core content of shareholder_vote_results disclosures.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-05-20
Item 1.01
Williams Companies entered into two material credit agreements on May 19, 2026: a Second Amended and Restated Credit Agreement ($3.75 billion aggregate commitment with $500 million expansion option) and a 364-Day Credit Agreement ($1.0 billion aggregate commitment with $150 million expansion option). These agreements establish the company's primary liquidity facilities and contain financial covenants (debt-to-EBITDA ratio of 5.00:1.00).
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 8.01
The disclosure announces positive Phase 3 and Phase 2 clinical trial data presented at a major medical congress. While this represents material clinical progress for a biopharmaceutical company that could affect investor assessment of pipeline value and regulatory prospects, it does not fit the earnings_release category (which typically applies to financial results) nor any other more specific event type. The clinical data announcement is material but best classified as other_material given the taxonomy's focus on financial and corporate governance events.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-05-20
Item 2.02
The filing discloses a press release announcing first quarter 2026 financial results under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The explicit reference to "issued a press release announcing the first quarter 2026 results" and attachment as Exhibit 99.1 confirms this is a periodic earnings disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-05-20
Item 7.01
This Item 7.01 Regulation FD Disclosure contains a Q&A addressing material business developments: Middle East disruption impacts, significant growth in customs brokerage driven by tariff refunds and regulatory complexity, AI/technology investments enhancing margins, and hyperscaler volume trends. While the disclosure is primarily forward-looking guidance and management commentary rather than a discrete event (M&A, restatement, departure, etc.), the substantive discussion of customs growth drivers, tariff refund activity, and technology initiatives would affect a reasonable investor's assessment of the company's near-term revenue and margin trajectory. This does not fit neatly into the more specific event categories but is material disclosure under Regulation FD.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-05-20
Item 1.01
Lumen and its subsidiary Qwest entered into a Support Agreement with noteholders to facilitate exchange offers for approximately $456 million of outstanding debt, involving the exchange of 6.5% Notes due 2056 and 6.75% Notes due 2057 for newly issued notes with extended expiration dates. This material capital structure modification affects investor assessment of the company's financial position and obligations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-05-20
Item 3.02
The Company disclosed the sale of 30,481 Class D Common Shares for $840,000 under a continuous private placement offering of up to $2.165 billion in unregistered equity securities pursuant to Section 4(a)(2) and Regulation D Rule 506(c). This is a classic dilutive issuance of unregistered equity securities, and the forward-looking statements explicitly warn that "future sales or issuances of our Common Shares or other securities convertible into our Common Shares, or the perception thereof, could cause the value of our Common Shares to decline and could result in dilution."
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
This is a clear disclosure of shareholder voting results from Amgen's Annual Meeting held May 19, 2026, covering four matters: election of 12 directors, advisory vote on executive compensation, ratification of Ernst & Young LLP as independent auditors, and a stockholder proposal on board chairman independence. Item 5.07 explicitly requires disclosure of shareholder vote results, and these outcomes are material to investors assessing board composition and governance.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 85%
filed 2026-05-20
Item 8.01
The filing discloses three lawsuits challenging the proposed merger between Stellar Bancorp and Prosperity Bancshares, filed in New York Supreme Court in May 2026, plus demand letters from purported shareholders. Although the companies deny merit and made supplemental disclosures to avoid litigation delays, the disclosure of material litigation related to a pending merger transaction is a core 8-K Item 8.01 event that would affect a reasonable investor's assessment of transaction risk and timing.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-05-20
Item 5.02
The filing discloses the appointment of Luke Wood to the board of directors following the board's approval to increase its size from twelve to thirteen members. While the section also mentions compensation under the Non-Employee Director Compensation Policy, the principal disclosed action is the appointment itself. The appointment of an experienced executive (former President of Beats by Dr. Dre and Apple VP) to the board is material to investors assessing governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-05-20
Item 5.07
AT&T held its 2026 Annual Meeting of Shareholders on May 14, 2026, with detailed voting results disclosed for director elections (10 nominees), board-sponsored proposals including auditor ratification, incentive plan approval, executive compensation advisory vote, and certificate amendments, as well as stockholder proposals on written consent rights and EEO-1 disclosure.
View raw filing on EDGAR →